Dysregulation of Amphiregulin stimulates the pathogenesis of cystic lymphangioma.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
11 05 2021
Historique:
entrez: 4 5 2021
pubmed: 5 5 2021
medline: 15 12 2021
Statut: ppublish

Résumé

Along with blood vessels, lymphatic vessels play an important role in the circulation of body fluid and recruitment of immune cells. Postnatal lymphangiogenesis commonly occurs from preexisting lymphatic vessels by sprouting, which is induced by lymphangiogenic factors such as vascular endothelial growth factor C (VEGF-C). However, the key signals and cell types that stimulate pathological lymphangiogenesis, such as human cystic lymphangioma, are less well known. Here, we found that mouse dermal fibroblasts that infiltrate to sponges subcutaneously implanted express VEGF-D and sushi, Von Willebrand factor type A, EGF, and pentraxin domain containing 1 (SVEP1) in response to PDGFRβ signal. In vitro,

Identifiants

pubmed: 33941693
pii: 2019580118
doi: 10.1073/pnas.2019580118
pmc: PMC8126796
pii:
doi:

Substances chimiques

AREG protein, human 0
Amphiregulin 0
Areg protein, mouse 0
Vascular Endothelial Growth Factor C 0
Vascular Endothelial Growth Factor D 0
Vegfd protein, mouse 0
Receptor, Platelet-Derived Growth Factor beta EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Circ Res. 2017 Apr 14;120(8):1263-1275
pubmed: 28179432
Am J Physiol Endocrinol Metab. 2010 Apr;298(4):E742-50
pubmed: 20028964
Development. 2017 Oct 1;144(19):3590-3601
pubmed: 28851707
Eur J Obstet Gynecol Reprod Biol. 2018 Dec;231:274-279
pubmed: 30482553
Semin Oncol. 2001 Oct;28(5 Suppl 16):27-32
pubmed: 11706393
Nat Immunol. 2004 Jan;5(1):74-80
pubmed: 14634646
Front Physiol. 2012 Jul 16;3:269
pubmed: 22934024
J Laryngol Otol. 2008 Nov;122(11):1260-4
pubmed: 18430261
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15983-8
pubmed: 16239343
EBioMedicine. 2018 May;31:190-201
pubmed: 29724654
Am J Pathol. 2002 Sep;161(3):929-38
pubmed: 12213721
Clin Sci (Lond). 2005 Sep;109(3):227-41
pubmed: 16104843
EMBO J. 2003 Jul 15;22(14):3546-56
pubmed: 12853470
Sci Rep. 2015 Feb 17;5:8505
pubmed: 25687367
Pathol Int. 2017 May;67(5):235-246
pubmed: 28393435
EMBO J. 1996 Jan 15;15(2):290-98
pubmed: 8617204
J Invest Dermatol. 2013 Aug;133(8):2074-84
pubmed: 23439394
Stem Cells. 2016 Mar;34(3):685-98
pubmed: 26435273
Am J Pathol. 2002 Sep;161(3):947-56
pubmed: 12213723
Circ Res. 2017 Apr 14;120(8):1276-1288
pubmed: 28179430
J Neurochem. 2006 Jul;98(2):588-600
pubmed: 16805849
J Biol Chem. 1995 Apr 21;270(16):9543-9
pubmed: 7721883
J Biol Chem. 2005 Mar 11;280(10):9375-89
pubmed: 15590688
Cell. 2010 Feb 19;140(4):460-76
pubmed: 20178740
J Biochem. 2012 Sep;152(3):213-20
pubmed: 22825883
J Pediatr. 2015 Apr;166(4):1048-54.e1-5
pubmed: 25681199
Pediatr Int. 2009 Oct;51(5):670-7
pubmed: 19419502
Eur Rev Med Pharmacol Sci. 2017 Nov;21(21):4918-4923
pubmed: 29164568
J Biol Chem. 2012 Jul 20;287(30):25615-30
pubmed: 22654117
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):548-53
pubmed: 9435229
J Dermatol Sci. 2013 Sep;71(3):184-94
pubmed: 23706492
J Clin Invest. 2005 Sep;115(9):2316-9
pubmed: 16138185
Cell Rep. 2019 Apr 23;27(4):1073-1089.e5
pubmed: 31018125
Cell Physiol Biochem. 2018;51(3):1461-1479
pubmed: 30485861
Sci Rep. 2015 Dec 07;5:17948
pubmed: 26639755
Bioessays. 1998 Jan;20(1):41-8
pubmed: 9504046

Auteurs

Naofumi Yoshida (N)

Department of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Department of Oral and Maxillofacial Surgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.

Seiji Yamamoto (S)

Department of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan; seiyama@med.u-toyama.ac.jp sasahara@med.u-toyama.ac.jp.

Takeru Hamashima (T)

Department of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.

Noriko Okuno (N)

Department of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.

Naruho Okita (N)

Department of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.

Shinjiro Horikawa (S)

Intensive Care Unit, Toyama Prefectural Central Hospital, Toyama 930-8550, Japan.

Masao Hayashi (M)

Department of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Department of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.

Thanh Chung Dang (TC)

Department of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Department of Pathophysiology, Vietnam Military Medical University, Hanoi, Vietnam.

Quang Linh Nguyen (QL)

Department of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.

Koichi Nishiyama (K)

International Research Center for Medical Sciences, Kumamoto University, 860-0811 Kumamoto, Japan.
Department of Medical Sciences, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1601, Japan.

Teruhiko Makino (T)

Department of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.

Yoko Ishii (Y)

Department of Health Science, Faculty of Health and Human Development, The University of Nagano, 380-8525 Nagano, Japan.

Kei Tomihara (K)

Department of Oral and Maxillofacial Surgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.

Tadamichi Shimizu (T)

Department of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.

Masabumi Shibuya (M)

Institute of Physiology and Medicine, Jobu University, Gunma 370-1393, Japan.

Makoto Noguchi (M)

Department of Oral and Maxillofacial Surgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.

Masakiyo Sasahara (M)

Department of Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan; seiyama@med.u-toyama.ac.jp sasahara@med.u-toyama.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH